All In Biotech

Drug Trial Radar · NCT03524092

A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis

A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)

Last checked: Nov 20, 2026Latest source record: May 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,328

Actual

Start

Oct 19, 2018

Primary completion

Nov 3, 2021

Study completion Feb 17, 2025

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
May 14, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Non randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy and safety of mirikizumab as maintenance therapy in participants who completed as clinical responders in the prior 12-week induction study LUCENT-1 (NCT03518086).

Conditions

  • Ulcerative Colitis

Interventions

  • Mirikizumab SCDrug

    Administered SC

  • Mirikizumab IVDrug

    Administered IV

  • Placebo SCDrug

    Administered SC

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants in Clinical Remission at Week 40 (Mirikizumab Induction Responders)Time frame: Week 40

Locations

385 sites in 34 countries. Site status is shown where the registry gives one.

  • Digestive Health Specialists of the Southeast

    Dothan, Alabama

  • Dcr-Pi, Pc

    Litchfield Park, Arizona

  • Maricopa Integrated Health System

    Phoenix, Arizona

  • Physicians Research Group

    Tempe, Arizona

  • Valley Gastroenterology

    Arcadia, California

  • Care Access Research

    Berkeley, California

  • Om Research, LLC

    Lancaster, California

  • California Medical Research Associates

    Northridge, California

  • Clinical Applications Laboratories, Inc.

    San Diego, California

  • UCSF Medical Center at Mission Bay

    San Francisco, California

  • Direct Helpers Research Center

    Hialeah, Florida

  • Nature Coast Clinical Research, LLC

    Inverness, Florida

  • SIH Research, LLC

    Kissimmee, Florida

  • Research Associates of South Florida, LLC

    Miami, Florida

  • Wellness Clinical Research

    Miami Lakes, Florida

  • Center for Interventional Endoscopy

    Orlando, Florida

  • Clintheory Healthcare

    Orlando, Florida

  • Gastroenterology Associates of Pensacola, PA

    Pensacola, Florida

  • Florida Medical Clinic LLC

    Zephyrhills, Florida

  • Digestive Healthcare of Georgia

    Atlanta, Georgia

  • Grand Teton Research Group

    Idaho Falls, Idaho

  • NorthShore University HealthSystem

    Evanston, Illinois

  • Indiana University School of Medicine

    Indianapolis, Indiana

  • Cotton-O'Neil Clinical Research Center, Digestive Health

    Topeka, Kansas

  • Texas Digestive Disease Consultants

    Baton Rouge, Louisiana

  • Delta Research Partners LLC

    Monroe, Louisiana

  • Nola Research Works, LLC

    New Orleans, Louisiana

  • Clinical Research Institute of Michigan, LLC

    Chesterfield, Michigan

  • Henry Ford Health System

    Novi, Michigan

  • Gastroenterology Associates of Western Michigan, P.L.C.

    Wyoming, Michigan

  • Huron Gastroenterology Associates

    Ypsilanti, Michigan

  • MNGI Digestive Health - Plymouth Endoscopy Center & Clinic

    Plymouth, Minnesota

  • Care Access Research LLC

    Jackson, Mississippi

  • Digestive Health Specialists

    Tupelo, Mississippi

  • Northwell Health

    Great Neck, New York

  • Weill Cornell Medical College

    New York, New York

  • University of North Carolina Center for Inflammatory Bowel Disease

    Chapel Hill, North Carolina

  • Carolina Digestive Diseases and Endoscopy Center

    Greenville, North Carolina

  • Paramount Medical Research

    Middleburg Heights, Ohio

  • Care Access - Youngstown

    Poland, Ohio

Showing 40 of 385 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.